- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
21
Companies with a Value score of at least 3, ordered by Value score
21 companies
Gilead Sciences
Market Cap: AR$177.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$58,300.00
7D
8.1%
1Y
49.9%
Bristol-Myers Squibb
Market Cap: AR$134.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$35,520.00
7D
5.4%
1Y
67.7%
Bristol-Myers Squibb
Market Cap: US$134.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$23.66
7D
7.7%
1Y
55.1%
Bayer
Market Cap: AR$48.3b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$31,080.00
7D
3.6%
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$6.90
7D
-0.3%
1Y
n/a
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,510.00
7D
-0.6%
1Y
n/a
GSK
Market Cap: US$76.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.54
7D
3.4%
1Y
35.4%
GSK
Market Cap: AR$76.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,910.00
7D
4.8%
1Y
59.6%
Gilead Sciences
Market Cap: US$177.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$37.82
7D
8.9%
1Y
26.5%
AstraZeneca
Market Cap: AR$186.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$65,125.00
7D
3.6%
1Y
23.1%
Tempus AI
Market Cap: AR$8.9b
Operates as a healthcare technology company in the United States.
TEM
AR$8,085.00
7D
12.8%
1Y
0.6%
Amgen
Market Cap: US$229.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$15.39
7D
6.4%
1Y
58.5%
Biogen
Market Cap: AR$31.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$26,880.00
7D
5.6%
1Y
91.7%
Vertex Pharmaceuticals
Market Cap: AR$133.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,650.00
7D
4.9%
1Y
69.3%
Biogen
Market Cap: US$31.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$17.69
7D
5.1%
1Y
79.4%
Amgen
Market Cap: AR$229.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$23,320.00
7D
6.0%
1Y
79.7%
Vertex Pharmaceuticals
Market Cap: US$133.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.73
7D
6.1%
1Y
49.0%
Novartis
Market Cap: AR$241.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$63,350.00
7D
4.6%
1Y
52.1%
Novartis
Market Cap: US$241.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$40.92
7D
1.9%
1Y
35.3%
Tempus AI
Market Cap: US$8.9b
Operates as a healthcare technology company in the United States.
TEMD
US$5.24
7D
11.6%
1Y
-13.2%
AstraZeneca
Market Cap: US$186.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$42.58
7D
4.2%
1Y
5.8%